Your browser doesn't support javascript.
loading
Protein O-GlcNAcylation as a nutrient sensor signaling placental dysfunction in hypertensive pregnancy.
Dos Passos Junior, Rinaldo Rodrigues; de Freitas, Raiany Alves; Dela Justina, Vanessa; San Martín, Sebastián; Lima, Victor Vitorino; Giachini, Fernanda Regina.
Afiliación
  • Dos Passos Junior RR; Graduate Program in Biological Sciences, Federal University of Goiás, Goiânia, Brazil.
  • de Freitas RA; Graduate Program in Biological Sciences, Federal University of Goiás, Goiânia, Brazil.
  • Dela Justina V; Institute of Biological and Health Sciences, Federal University of Mato Grosso, Barra do Garças, Brazil.
  • San Martín S; Biomedical Research Center, School of Medicine, Universidad de Valparaíso, Valparaíso, Chile.
  • Lima VV; Institute of Biological and Health Sciences, Federal University of Mato Grosso, Barra do Garças, Brazil.
  • Giachini FR; Graduate Program in Biological Sciences, Federal University of Goiás, Goiânia, Brazil.
Front Endocrinol (Lausanne) ; 13: 1032499, 2022.
Article en En | MEDLINE | ID: mdl-36531508
ABSTRACT

Introduction:

During pregnancy, arterial hypertension may impair placental function, which is critical for a healthy baby's growth. Important proteins during placentation are known to be targets for O-linked ß-N-acetylglucosamine modification (O-GlcNAcylation), and abnormal protein O-GlcNAcylation has been linked to pathological conditions such as hypertension. However, it is unclear how protein O-GlcNAcylation affects placental function and fetal growth throughout pregnancy during hypertension.

Methods:

To investigate this question, female Wistar and spontaneously hypertensive rats (SHR) were mated with male Wistar rats, and after pregnancy confirmation by vaginal smear, rats were divided into groups of 14, 17, and 20 days of pregnancy (DOPs). On the 14th, 17th, and 20th DOP, rats were euthanized, fetal parameters were measured, and placentas were collected for western blot, immunohistochemical, and morphological analyses.

Results:

SHR presented a higher blood pressure than the Wistar rats (p=0.001). Across all DOPs, SHR showed reduced fetal weight and an increase in small-for-gestational-age fetuses. While near-term placentas were heavier in SHR (p=0.006), placental efficiency decreased at 17 (p=0.01) and 20 DOPs (p<0.0001) in this group. Morphological analysis revealed reduced junctional zone area and labyrinth vasculature changes on SHR placentas in all DOPs. O-GlcNAc protein expression was lower in placentas from SHR compared with Wistar at 14, 17, and 20 DOPs. Decreased expression of O-GlcNAc transferase (p=0.01) and O-GlcNAcase (p=0.002) enzymes was found at 14 DOPs in SHR. Immunohistochemistry showed reduced placental O-GlcNAc content in both the junctional zone and labyrinth of the placentas from SHR. Periodic acid-Schiff analysis showed decreased glycogen cell content in the placentas from SHR at 14, 17, and 20 DOPs. Moreover, glucose transporter 1 expression was decreased in placentas from SHR in all DOPs.

Conclusions:

These findings suggest that decreased protein O-GlcNAcylation caused by insufficient placental nutritional apport contributes to placental dysfunction during hypertensive pregnancy, impairing fetal growth.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placenta / Hipertensión Límite: Animals / Pregnancy Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Placenta / Hipertensión Límite: Animals / Pregnancy Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Brasil
...